These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 22147259)
1. Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal. Stoker AK; Olivier B; Markou A Psychopharmacology (Berl); 2012 May; 221(2):317-27. PubMed ID: 22147259 [TBL] [Abstract][Full Text] [Related]
2. Null mutation of the β2 nicotinic acetylcholine receptor subunit attenuates nicotine withdrawal-induced anhedonia in mice. Stoker AK; Marks MJ; Markou A Eur J Pharmacol; 2015 Apr; 753():146-50. PubMed ID: 25107281 [TBL] [Abstract][Full Text] [Related]
3. Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice. Stoker AK; Olivier B; Markou A Behav Genet; 2012 May; 42(3):423-36. PubMed ID: 22009521 [TBL] [Abstract][Full Text] [Related]
4. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats. Liechti ME; Markou A Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075 [TBL] [Abstract][Full Text] [Related]
5. Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies. Johnson PM; Hollander JA; Kenny PJ Pharmacol Biochem Behav; 2008 Sep; 90(3):409-15. PubMed ID: 18466962 [TBL] [Abstract][Full Text] [Related]
6. Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice. Stoker AK; Semenova S; Markou A Neuropharmacology; 2008 Jun; 54(8):1223-32. PubMed ID: 18452957 [TBL] [Abstract][Full Text] [Related]
7. Sex differences in the reward deficit and somatic signs associated with precipitated nicotine withdrawal in rats. Tan S; Xue S; Behnood-Rod A; Chellian R; Wilson R; Knight P; Panunzio S; Lyons H; Febo M; Bruijnzeel AW Neuropharmacology; 2019 Dec; 160():107756. PubMed ID: 31487496 [TBL] [Abstract][Full Text] [Related]
8. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. Watkins SS; Stinus L; Koob GF; Markou A J Pharmacol Exp Ther; 2000 Mar; 292(3):1053-64. PubMed ID: 10688623 [TBL] [Abstract][Full Text] [Related]
9. Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats. Kenny PJ; Boutrel B; Gasparini F; Koob GF; Markou A Psychopharmacology (Berl); 2005 Apr; 179(1):247-54. PubMed ID: 15602687 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal. Jackson A; Papke RL; Damaj MI Psychopharmacology (Berl); 2018 Jul; 235(7):1897-1905. PubMed ID: 29549391 [TBL] [Abstract][Full Text] [Related]
11. Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats. Bruijnzeel AW; Bishnoi M; van Tuijl IA; Keijzers KF; Yavarovich KR; Pasek TM; Ford J; Alexander JC; Yamada H Psychopharmacology (Berl); 2010 Dec; 212(4):485-99. PubMed ID: 20697697 [TBL] [Abstract][Full Text] [Related]
12. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. Kenny PJ; Gasparini F; Markou A J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481 [TBL] [Abstract][Full Text] [Related]
13. A Two-Day Continuous Nicotine Infusion Is Sufficient to Demonstrate Nicotine Withdrawal in Rats as Measured Using Intracranial Self-Stimulation. Muelken P; Schmidt CE; Shelley D; Tally L; Harris AC PLoS One; 2015; 10(12):e0144553. PubMed ID: 26658557 [TBL] [Abstract][Full Text] [Related]
14. Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats. Paterson NE; Markou A Psychopharmacology (Berl); 2004 Apr; 173(1-2):64-72. PubMed ID: 14712336 [TBL] [Abstract][Full Text] [Related]
15. Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats. Bruijnzeel AW; Ford J; Rogers JA; Scheick S; Ji Y; Bishnoi M; Alexander JC Pharmacol Biochem Behav; 2012 Mar; 101(1):62-8. PubMed ID: 22182462 [TBL] [Abstract][Full Text] [Related]
16. Withdrawal from repeated nicotine vapor exposure increases somatic signs of physical dependence, anxiety-like behavior, and brain reward thresholds in adult male rats. Martínez M; Espinoza VE; Garcia V; Uribe KP; Negishi K; Estevao IL; Carcoba LM; O'Dell LE; Khan AM; Mendez IA Neuropharmacology; 2023 Dec; 240():109681. PubMed ID: 37611823 [TBL] [Abstract][Full Text] [Related]
17. Mecamylamine elicits withdrawal-like signs in rats following a single dose of nicotine. Harris AC; Manbeck KE; Schmidt CE; Shelley D Psychopharmacology (Berl); 2013 Jan; 225(2):291-302. PubMed ID: 22868410 [TBL] [Abstract][Full Text] [Related]
18. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Cryan JF; Bruijnzeel AW; Skjei KL; Markou A Psychopharmacology (Berl); 2003 Jul; 168(3):347-58. PubMed ID: 12698231 [TBL] [Abstract][Full Text] [Related]
19. Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats. Rylkova D; Boissoneault J; Isaac S; Prado M; Shah HP; Bruijnzeel AW Neuropeptides; 2008 Jun; 42(3):215-27. PubMed ID: 18468678 [TBL] [Abstract][Full Text] [Related]
20. Metabotropic glutamate 2/3 receptor activation induced reward deficits but did not aggravate brain reward deficits associated with spontaneous nicotine withdrawal in rats. Liechti ME; Markou A Biochem Pharmacol; 2007 Oct; 74(8):1299-307. PubMed ID: 17601493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]